참고문헌
- Williams A. Calculating the global burden of disease: time for a strategic reappraisal? Health Econ 1999;8(1):1-8. https://doi.org/10.1002/(SICI)1099-1050(199902)8:1<1::AID-HEC399>3.0.CO;2-B
- Meropol NJ, Schulman KA. Cost of cancer care: issues and implications. J Clin Oncol 2007;25(2):180-186. https://doi.org/10.1200/JCO.2006.09.6081
- Yoon SJ, Lee H, Shin Y, Kim YI, Kim CY, Chang H. Estimation of the burden of major cancers in Korea. J Korean Med Sci 2002; 17(5):604-610. https://doi.org/10.3346/jkms.2002.17.5.604
- Yoon SJ, Bae SC. Current scope and perspective of burden of disease study based on health related quality of life. J Korean Med Assoc 2004;47(7):600-602 (Korean). https://doi.org/10.5124/jkma.2004.47.7.600
- Gong YH, Yoon SJ, Jo MW, Kim A, Kim YA, Yoon J, et al. The burden of cancer in Korea during 2012: findings from a prevalence-based approach. J Korean Med Sci 2016;31 Suppl 2: S168-S177. https://doi.org/10.3346/jkms.2016.31.S2.S168
- Yoon SJ, Bae SC, Lee SI, Chang H, Jo HS, Sung JH, et al. Measuring the burden of disease in Korea. J Korean Med Sci 2007; 22(3):518-523. https://doi.org/10.3346/jkms.2007.22.3.518
- Yoon J, Oh IH, Seo H, Kim EJ, Gong YH, Ock M, et al. Disabilityadjusted life years for 313 diseases and injuries: the 2012 Korean Burden of Disease Study. J Korean Med Sci 2016;31 Suppl 2:S146-S157. https://doi.org/10.3346/jkms.2016.31.S2.S146
- Soerjomataram I, Lortet-Tieulent J, Ferlay J, Forman D, Mathers C, Parkin DM, et al. Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer. BMC Med Res Methodol 2012;12:125. https://doi.org/10.1186/1471-2288-12-125
- Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, Lee KH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat 2017;49(2):292-305. https://doi.org/10.4143/crt.2017.118
- Jung KW, Shin HR, Kong HJ, Park S, Won YJ, Choi KS, et al. Long-term trends in cancer mortality in Korea (1983-2007): a joinpoint regression analysis. Asian Pac J Cancer Prev 2010; 11(6):1451-1457.
- Kim YA, Oh IH, Yoon SJ, Kim HJ, Seo HY, Kim EJ, et al. The economic burden of breast cancer in Korea from 2007-2010. Cancer Res Treat 2015;47(4):583-590. https://doi.org/10.4143/crt.2014.143
- Schnipper LE, Meropol NJ, Brock DW. Value and cancer care: toward an equitable future. Clin Cancer Res 2010;16(24):6004-6008. https://doi.org/10.1158/1078-0432.CCR-10-1643
- Ljung R, Peterson S, Hallqvist J, Heimerson I, Diderichsen F. Socioeconomic differences in the burden of disease in Sweden. Bull World Health Organ 2005;83(2):92-99.
- Savage P, Mahmoud S. Development and economic trends in cancer therapeutic drugs: a 5-year update 2010-2014. Br J Cancer 2015;112(6):1037-1041. https://doi.org/10.1038/bjc.2015.56
- Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010; 376(9747):1186-1193. https://doi.org/10.1016/S0140-6736(10)61152-X
- Steenland K, Armstrong B. An overview of methods for calculating the burden of disease due to specific risk factors. Epidemiology 2006;17(5):512-519. https://doi.org/10.1097/01.ede.0000229155.05644.43
- Kim EJ, Yoon SJ, Jo MW, Kim HJ. Measuring the burden of chronic diseases in Korea in 2007. Public Health 2013;127(9): 806-813. https://doi.org/10.1016/j.puhe.2012.12.024
- Suh M, Choi KS, Park B, Lee YY, Jun JK, Lee DH, et al. Trends in cancer screening rates among Korean men and women: results of the Korean National Cancer Screening Survey, 2004-2013. Cancer Res Treat 2016;48(1):1-10. https://doi.org/10.4143/crt.2014.204
- Loberg M, Lousdal ML, Bretthauer M, Kalager M. Benefits and harms of mammography screening. Breast Cancer Res 2015; 17:63. https://doi.org/10.1186/s13058-015-0525-z
- Gotzsche PC, Jorgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;(6):CD00 1877.
- Bae JM. Overdiagnosis: epidemiologic concepts and estimation. Epidemiol Health 2015;37:e2015004. https://doi.org/10.4178/epih/e2015004
- Bae JM. Epidemiological evidences on overdiagnosis of prostate and kidney cancers in Korean. Epidemiol Health 2015;37: e2015015. https://doi.org/10.4178/epih/e2015015
- Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010;102(9):605-613. https://doi.org/10.1093/jnci/djq099
- Bae JM. It needs adaptation to the 2015 Korean guideline for breast cancer screening. J Korean Med Assoc 2015;58(9):833-837 (Korean). https://doi.org/10.5124/jkma.2015.58.9.833
- Jameson JL, Longo DL. Precision medicine: personalized, problematic, and promising. N Engl J Med 2015;372(23):2229-2234. https://doi.org/10.1056/NEJMsb1503104
- Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, et al. Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2009;7(2):122-192. https://doi.org/10.6004/jnccn.2009.0012
- Studdert DM, Mello MM, Sage WM, DesRoches CM, Peugh J, Zapert K, et al. Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA 2005; 293(21):2609-2617. https://doi.org/10.1001/jama.293.21.2609
- Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 2008;26(23):3860-3866. https://doi.org/10.1200/JCO.2007.15.8253
- Brook RH. Assessing the appropriateness of care--its time has come. JAMA 2009;302(9):997-998. https://doi.org/10.1001/jama.2009.1279
- Dalton WS, Sullivan DM, Yeatman TJ, Fenstermacher DA. The 2010 Health Care Reform Act: a potential opportunity to advance cancer research by taking cancer personally. Clin Cancer Res 2010;16(24):5987-5996. https://doi.org/10.1158/1078-0432.CCR-10-1216
- Bae JM. Value-based medicine: concepts and application. Epidemiol Health 2015;37:e2015014. https://doi.org/10.4178/epih/e2015014
- Bae JM. Development and application of patient decision aids. Epidemiol Health 2015;37:e2015018. https://doi.org/10.4178/epih/e2015018
- Bae JM. Academic strategies based on evidence-practice gaps. Hanyang Med Rev 2015;35(1):3-8 (Korean). https://doi.org/10.7599/hmr.2015.35.1.3
- Fujimori M, Uchitomi Y. Preferences of cancer patients regarding communication of bad news: a systematic literature review. Jpn J Clin Oncol 2009;39(4):201-216. https://doi.org/10.1093/jjco/hyn159
- Grunfeld E, Folkes A, Urquhart R. Do available questionnaires measure the communication factors that patients and families consider important at end of life? J Clin Oncol 2008;26 (23):3874-3878. https://doi.org/10.1200/JCO.2007.15.8006
- Pollak KI, Arnold RM, Jeffreys AS, Alexander SC, Olsen MK, Abernethy AP, et al. Oncologist communication about emotion during visits with patients with advanced cancer. J Clin Oncol 2007;25(36):5748-5752. https://doi.org/10.1200/JCO.2007.12.4180
- McFarlane J, Riggins J, Smith TJ. SPIKE$: a six-step protocol for delivering bad news about the cost of medical care. J Clin Oncol 2008;26(25):4200-4204. https://doi.org/10.1200/JCO.2007.15.6208
- Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 2009;27(23): 3868-3874. https://doi.org/10.1200/JCO.2009.23.1183
- Brown MM, Brown GC, Sharma S, Landy J. Health care economic analyses and value-based medicine. Surv Ophthalmol 2003;48(2):204-223. https://doi.org/10.1016/S0039-6257(02)00457-5
- Brown MM, Brown GC, Sharma S, Stein JD, Roth Z, Campanella J, et al. The burden of age-related macular degeneration: a value-based analysis. Curr Opin Ophthalmol 2006;17(3):257-266.
- Neumann PJ, Palmer JA, Nadler E, Fang C, Ubel P. Cancer therapy costs influence treatment: a national survey of oncologists. Health Aff (Millwood) 2010;29(1):196-202. https://doi.org/10.1377/hlthaff.2009.0077
- Lenz M, Buhse S, Kasper J, Kupfer R, Richter T, Muhlhauser I. Decision aids for patients. Dtsch Arztebl Int 2012;109(22-23):401-408.
- Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PK, et al. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak 2013;13 Suppl 2:S7.
- Stacey D, Legare F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2017;4:CD001431.
- O'Connor AM, Llewellyn-Thomas HA, Flood AB. Modifying unwarranted variations in health care: shared decision making using patient decision aids. Health Aff (Millwood) 2004;Suppl Variation:VAR63-VAR72.
- Doring AC, Hageman MG, Mulder FJ, Guitton TG, Ring D; Science of Variation Group, et al. Trigger finger: assessment of surgeon and patient preferences and priorities for decision making. J Hand Surg Am 2014;39(11):2208-2213.e2. https://doi.org/10.1016/j.jhsa.2014.08.010
- O'Connor AM, Wennberg JE, Legare F, Llewellyn-Thomas HA, Moulton BW, Sepucha KR, et al. Toward the 'tipping point': decision aids and informed patient choice. Health Aff (Millwood) 2007;26(3):716-725. https://doi.org/10.1377/hlthaff.26.3.716
피인용 문헌
- Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention vol.13, pp.40, 2017, https://doi.org/10.5712/rbmfc13(40)1860
- 보건의료체계 지속가능성의 필수 조건들 vol.16, pp.2, 2017, https://doi.org/10.22730/jmls.2019.16.2.52